Guidant Ventak VR
This article was originally published in The Gray Sheet
Implantable cardioverter defibrillator debuts in the U.S. following FDA market go-ahead May 6. The 51 cc ICD incorporates single-chamber, adaptive-rate pacing and will compete with Medtronic's 48 cc Gem SR ICD with single-chamber, adaptive-rate pacing. The Gem SR was approved in October 1998
You may also be interested in...
Under EU rules, once a medicinal product has been placed on the market in a country of the EEA – the EU plus Iceland, Liechtenstein and Norway
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
The national regulator is to undergo a review in 2021 as the UK begins life as a former EU member, presenting opportunities to be seized.